[1]
|
Lam, E.W., Brosens, J.J., Gomes, A.R., et al. (2013) Forkhead Box Proteins: Tuning Forks for Transcriptional Harmony. Nature Reviews Cancer, 13, 482-495. https://doi.org/10.1038/nrc3539
|
[2]
|
Yu, C., Li, X., Zhao, Y., et al. (2023) The Role of FOXA Family Transcription Factors in Glucolipid Metabolism and NAFLD. Frontiers in Endocrinology, 14, Article 1081500. https://doi.org/10.3389/fendo.2023.1081500
|
[3]
|
白仲虎, 李璐, 戴晓峰. 转录因子 FOXA1在乳腺癌分子分型中的功能研究[J]. 生物学杂志, 2017, 34(1): 5-10.
|
[4]
|
Castaneda, M., Hollander, P.D. and Mani, S.A. (2022) Forkhead Box Transcription Factors: Double-Edged Swords in Cancer. Cancer Research, 82, 2057-2065. https://doi.org/10.1158/0008-5472.CAN-21-3371
|
[5]
|
Liu, Z., Wang, Y., Aizimuaji, Z., et al. (2022) Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer Due to Its Effects on Cell Proliferation and Metastasis. Disease Markers, 2022, Article ID: 3317315. https://doi.org/10.1155/2022/3317315
|
[6]
|
Horimoto, Y., Sasahara, N., Sasaki, R., et al. (2020) High FOXA1 Protein Expression Might Predict Late Recurrence in Patients with Estrogen-Positive and HER2-Negative Breast Cancer. Breast Cancer Research and Treatment, 183, 41-48. https://doi.org/10.1007/s10549-020-05751-x
|
[7]
|
Su, Y., Zhang, Y., Zhao, J., et al. (2021) FOXA1 Promotes Prostate Cancer Angiogenesis by Inducing Multiple Pro-Angiogenic Factors Expression. Journal of Cancer Research and Clinical Oncology, 147, 3225-3243. https://doi.org/10.1007/s00432-021-03730-3
|
[8]
|
Chen, G., Wei, R.S., Ma, J., et al. (2023) FOXA1 Prolongs S Phase and Promotes Cancer Progression in Non-Small Cell Lung Cancer through Upregulation of CDC5L and Activation of the ERK1/2 and JAK2 Pathways. The Kaohsiung Journal of Medical Sciences, 39, 1077-1086. https://doi.org/10.1002/kjm2.12737
|
[9]
|
Pan, J., Xu, Z., Xu, M., et al. (2020) Knockdown of Forkhead Box A1 Suppresses the Tumorigenesis and Progression of Human Colon Cancer Cells through Regulating the Phosphatase and Tensin Homolog/Akt Pathway. Journal of International Medical Research, 48. https://doi.org/10.1177/0300060520971453
|
[10]
|
Siegel, R.L., Miller, K.D., Wagle, N.S., et al. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763
|
[11]
|
Wang, Y., Yang, L., Chen, T., et al. (2019) A Novel LncRNA MCM3AP-AS1 Promotes the Growth of Hepatocellular Carcinoma by Targeting MiR-194-5p/FOXA1 Axis. Molecular Cancer, 18, Article No. 28. https://doi.org/10.1186/s12943-019-0957-7
|
[12]
|
Yuan, Z., Ye, M., Qie, J., et al. (2020) FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating MiR-212-3p/FOXA1/AGR2 Signaling Pathway. OncoTargets and Therapy, 13, 5231-5240. https://doi.org/10.2147/OTT.S252890
|
[13]
|
Iacoviello, L., Bonaccio, M., De Gaetano, G., et al. (2021) Epidemiology of Breast Cancer, a Paradigm of the “Common Soil” Hypothesis. Seminars in Cancer Biology, 72, 4-10. https://doi.org/10.1016/j.semcancer.2020.02.010
|
[14]
|
Zhou, M., Gan, X.L., Ren, Y.X., et al. (2023) AGR2 and FOXA1 As Prognostic Markers in ER-Positive Breast Cancer. BMC Cancer, 23, Article No. 743. https://doi.org/10.1186/s12885-023-10964-6
|
[15]
|
张继君, 陶丽丽, 赵夫娟, 等. FOXA1、GATA-3与ER在乳腺癌中的表达及预后意义[J]. 暨南大学学报(自然科学与医学版), 2019, 40(3): 225-233.
|
[16]
|
Jing, X., Liang, H., Hao, C., et al. (2019) Analyses of An Epigenetic Switch Involved in the Activation of Pioneer Factor FOXA1 Leading to the Prognostic Value of Estrogen Receptor and FOXA1 Co-Expression in Breast Cancer. Aging, 11, 7442-7456. https://doi.org/10.18632/aging.102250
|
[17]
|
Benayed-Guerfali, D., Dabbeche-Bouricha, E., Ayadi, W., et al. (2019) Association of FOXA1 and EMT Markers (Twist1 and E-Cadherin) in Breast Cancer. Molecular Biology Reports, 46, 3247-3255. https://doi.org/10.1007/s11033-019-04784-w
|
[18]
|
Xu, Y., Qin, L., Sun, T., et al. (2017) Twist1 Promotes Breast Cancer Invasion and Metastasis by Silencing Foxa1 Expression. Oncogene, 36, 1157-1166. https://doi.org/10.1038/onc.2016.286
|
[19]
|
Liu, J., Dong, L., Zhu, Y., et al. (2022) Prostate Cancer Treatment—China’s Perspective. Cancer Letters, 550, Article ID: 215927. https://doi.org/10.1016/j.canlet.2022.215927
|
[20]
|
Dong, H.Y., Ding, L., Zhou, T.R., et al. (2023) FOXA1 in Prostate Cancer. Asian Journal of Andrology, 25, 287-295. https://doi.org/10.4103/aja202259
|
[21]
|
Teng, M., Zhou, S., Cai, C., et al. (2021) Pioneer of Prostate Cancer: Past, Present and the Future of FOXA1. Protein & Cell, 12, 29-38. https://doi.org/10.1007/s13238-020-00786-8
|
[22]
|
Wang, X., Brea, L., Lu, X., et al. (2022) FOXA1 Inhibits Hypoxia Programs through Transcriptional Repression of HIF1A. Oncogene, 41, 4259-4270. https://doi.org/10.1038/s41388-022-02423-6
|
[23]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[24]
|
《中国吸烟危害健康报告2020》编写组. 《中国吸烟危害健康报告2020》概要[J]. 中国循环杂志, 2021, 36(10): 937-952.
|
[25]
|
Li, J., Zhang, S., Zhu, L., et al. (2018) Role of Transcription Factor FOXA1 in Non-Small Cell Lung Cancer. Molecular Medicine Reports, 17, 509-521. https://doi.org/10.3892/mmr.2017.7885
|
[26]
|
Li, G.S., Chen, G., Liu, J., et al. (2022) Clinical Significance of Cyclin-Dependent Kinase Inhibitor 2C Expression in Cancers: From Small Cell Lung Carcinoma to Pan-Cancers. BMC Pulmonary Medicine, 22, Article No. 246. https://doi.org/10.1186/s12890-022-02036-5
|
[27]
|
Dorso, M., Patel, P.T., Pankov, A., et al. (2023) A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in A Subset of Non-Small Cell Lung Cancer. Cancer Research Communications, 3, 1788-1799. https://doi.org/10.1158/2767-9764.CRC-23-0310
|
[28]
|
Fang, X.Q., Lee, M., Lim, W.J., et al. (2022) PGC1α Cooperates with FOXA1 to Regulate Epithelial Mesenchymal Transition through the TCF4-TWIST1. International Journal of Molecular Sciences, 23, Article 8247. https://doi.org/10.3390/ijms23158247
|
[29]
|
Dekker, E., Tanis, P.J., Vleugels, J.L, A., et al. (2019) Colorectal Cancer. Lancet, 394, 1467-1480. https://doi.org/10.1016/S0140-6736(19)32319-0
|
[30]
|
Wang, H. (2020) MicroRNAs and Apoptosis in Colorectal Cancer. International Journal of Molecular Sciences, 21, Article 5353. https://doi.org/10.3390/ijms21155353
|
[31]
|
Park, Y.L., Kim, S.H., Park, S.Y., et al. (2019) Forkhead-Box A1 Regulates Tumor Cell Growth and Predicts Prognosis in Colorectal Cancer. International Journal of Oncology, 54, 2169-2178. https://doi.org/10.3892/ijo.2019.4771
|
[32]
|
Lazar, S.B., Pongor, L., Li, X.L., et al. (2020) Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells. Molecular and Cellular Biology, 40, e00224-20. https://doi.org/10.1128/MCB.00224-20
|
[33]
|
Cong, K., Li, C.G., Wei, Y.H., et al. (2019) MicroRNA-760 Inhibits the Biological Progression of Colorectal Carcinoma by Directly Targeting FOXA1 and Regulating Epithelial-To-Mesenchymal Transition and PI3K/AKT Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 5730-5740.
|
[34]
|
Yang, W.J., Zhao, H.P., Yu, Y., et al. (2023) Updates on Global Epidemiology, Risk and Prognostic Factors of Gastric Cancer. World Journal of Gastroenterology, 29, 2452-2468. https://doi.org/10.3748/wjg.v29.i16.2452
|
[35]
|
Zhang, Z., Zhu, T., Zhang, L., et al. (2023) Critical Influence of Cytokines and Immune Cells in Autoimmune Gastritis. Autoimmunity, 56, Article ID: 2174531. https://doi.org/10.1080/08916934.2023.2174531
|
[36]
|
Hu, Y., Zhu, Y. and Lu, N.H. (2022) The Management of Helicobacter pylori Infection and Prevention and Control of Gastric Cancer in China. Frontiers in Cellular and Infection Microbiology, 12, Article 1049279. https://doi.org/10.3389/fcimb.2022.1049279
|
[37]
|
Peng, W., Chen, L. and Liu, J. (2023) Celastrol Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion via the FOXA1/CLDN4 Axis. Toxicology Research, 12, 392-399. https://doi.org/10.1093/toxres/tfad024
|
[38]
|
Hu, X., Zhou, S., Li, H., et al. (2023) FOXA1/MND1/TKT Axis Regulates Gastric Cancer Progression and Oxaliplatin Sensitivity via PI3K/AKT Signaling Pathway. Cancer Cell International, 23, Article No. 234. https://doi.org/10.1186/s12935-023-03077-4
|
[39]
|
Zhu, Y., Zhou, J., Zhu, L., et al. (2022) Adoptive Tumor Infiltrating Lymphocytes Cell Therapy for Cervical Cancer. Human Vaccines & Immunotherapeutics, 18, Article ID: 2060019. https://doi.org/10.1080/21645515.2022.2060019
|
[40]
|
Wang, Z., Sun, B.S., Chen, Z.S., et al. (2022) FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance. Analytical Cellular Pathology, 2022, Article ID: 9675466. https://doi.org/10.1155/2022/9675466
|
[41]
|
Zheng, Z.J., Liu, Y., Wang, H.J., et al. (2020) LncRNA SNHG17 Promotes Proliferation and Invasion of Ovarian Cancer Cells through Up-Regulating FOXA1. European Review for Medical and Pharmacological Sciences, 24, 9282-9289.
|
[42]
|
Ammous-Boukhris, N., Ayadi, W., Derbel, M., et al. (2020) FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers. BioMed Research International, 2020, Article ID: 4234632. https://doi.org/10.1155/2020/4234632
|
[43]
|
Urano, M., Hirai, H., Tada, Y., et al. (2018) The High Expression of FOXA1 Is Correlated with a Favourable Prognosis in Salivary Duct Carcinomas: A Study of 142 Cases. Histopathology, 73, 943-952. https://doi.org/10.1111/his.13706
|